Inicio › Linfoma folicular › Texas
Ensayos clínicos de Linfoma folicular en Texas
37 estudios sobre Linfoma folicular buscan participantes en Texas.
Ciudades en Texas
Texto oficial del estudio (inglés)
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NEXT Dallas, Irving
- NEXT Oncology, San Antonio
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT03460977A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
- University of Texas-MD Anderson Cancer Center ( Site 1323), Houston
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07634471A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Center for Oncology and Blood Disorders, Houston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06091254A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- University of Texas Southwestern, Dallas
- MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07101328A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Texas Oncology - DFW (Sammons CC), Dallas
- Baylor College of Medicine, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07226843Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
- Ben Taub General Hospital, Houston
ReclutandoFase 3
Edades de 12 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07215910Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
ReclutandoEstudio observacional
Edades de 0 a 38 · Todos los sexos · Actualizado el 29 oct 2026 · NCT06131801A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Baylor Scott & White Research Institute, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 oct 2026 · NCT05765812Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
- M D Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06108232Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 13 a 90 · Todos los sexos · Actualizado el 26 oct 2026 · NCT06533579A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
- Research Site, San Antonio
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 85 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07546760A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Austin
- Research Site, Lubbock
- Research Site, Shenandoah
- y 1 más
ReclutandoFase 3
Edades de 18 a 130 · Todos los sexos · Actualizado el 21 oct 2026 · NCT06549595SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Texas Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
- University of Texas Health Mays Cancer Center, San Antonio
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT05303519A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- The University of TX MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT07424833Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Austin
- Research Site, Houston
- Research Site, San Antonio
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06526793A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Md Anderson Cancer Center, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT05006716A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Houston
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT06542250NEO100 and High-Grade Meningioma
- Baylor Scott and White, Dallas
ReclutandoFase 2
Edades de 12 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT05023018Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Texas Oncology, Dallas
ReclutandoFase 3
Edades de 12 a 100 · Todos los sexos · Actualizado el 11 sept 2026 · NCT06784752A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
- MD Anderson Cancer Center, Houston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06043323Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Baylor University Medical Center, Dallas
- Texas Transplant Institute, San Antonio
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT05826535Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
- Natera, Inc., Austin
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT07750886Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
- Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
- The University of Texas Health Science at San Antonio, San Antonio
ReclutandoFase 2
Edades de 18 a 55 · Todos los sexos · Actualizado el 15 jul 2026 · NCT05951777A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jul 2026 · NCT05131022A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Texas Liver Institute - American Research Corporation, San Antonio
- Pinnacle Clinical Research, San Antonio
ReclutandoFase 1
Edades de 18 a 80 · Todos los sexos · Actualizado el 16 jun 2026 · NCT07559474A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Texas Oncology - Central/South Texas, Austin
- Local Institution - 0212, Fort Worth
- Local Institution - 0230, San Antonio
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 may 2026 · NCT06911502The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
ReclutandoFase 1/2
Edades de 12 a 95 · Todos los sexos · Actualizado el 15 abr 2026 · NCT04329728A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 mar 2026 · NCT04830137Study of SGR-1505 in Mature B-Cell Neoplasms
- University of Texas Southwestern, Dallas
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT05544019Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
- University of Texas Medical Branch at Galveston, TX, Galveston
Reclutando
Edades de 50 en adelante · Mujeres · Actualizado el 11 feb 2026 · NCT07206121Cognitive Screening Made Easy for PCPs - Administrative Supplement
- Family Wellness Clinic, Austin
- University of Texas Health Austin Primary Care Clinic, Austin
- UT Health San Antonio's Geriatrics and Supportive Care Clinic, San Antonio
ReclutandoSe aceptan voluntarios sanos
Edades de 60 en adelante · Todos los sexos · Actualizado el 5 feb 2026 · NCT06928298AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Oncology Consultants, Houston
- University of Texas MD Anderson Cancer Center, Houston
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 dic 2025 · NCT05602363A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- SCRI, San Antonio
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 nov 2025 · NCT05643742SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- University of Texas Southwestern Medical Center, Dallas
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2025 · NCT05780034Phosphatidylethanol and Other Ethanol Consumption Markers
- University of North Texas, Denton
- University of Texas Health Science Center San Antonio, San Antonio
ReclutandoSe aceptan voluntarios sanos
Edades de 21 en adelante · Todos los sexos · Actualizado el 13 may 2025 · NCT06747364Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 9 jul 2024 · NCT06444841De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.